Detalhe da pesquisa
1.
LAG3+ Regulatory T Cells Restrain Interleukin-23-Producing CX3CR1+ Gut-Resident Macrophages during Group 3 Innate Lymphoid Cell-Driven Colitis.
Immunity
; 49(2): 342-352.e5, 2018 08 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30097293
2.
Leukotriene B4 receptor 1 (BLT1) does not mediate disease progression in a mouse model of liver fibrosis.
Biochem J
; 2023 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38014500
3.
Oncolytic virus V937 in combination with PD-1 blockade therapy to target immunologically quiescent liver and colorectal cancer.
Mol Ther Oncol
; 32(2): 200807, 2024 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38745749
4.
Regenerating islet-derived family member, 4 modulates multiple receptor tyrosine kinases and mediators of drug resistance in cancer.
Int J Cancer
; 130(6): 1251-63, 2012 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21445968
5.
Effects of soluble guanylate cyclase stimulator on renal function in ZSF-1 model of diabetic nephropathy.
PLoS One
; 17(1): e0261000, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35085251
6.
ILT3 (LILRB4) Promotes the Immunosuppressive Function of Tumor-Educated Human Monocytic Myeloid-Derived Suppressor Cells.
Mol Cancer Res
; 19(4): 702-716, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33372059
7.
Combination of EP4 antagonist MF-766 and anti-PD-1 promotes anti-tumor efficacy by modulating both lymphocytes and myeloid cells.
Oncoimmunology
; 10(1): 1896643, 2021 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33796403
8.
Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin.
Breast Cancer Res
; 12(3): R32, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20525379
9.
Antitumor efficacy of combined CTLA4/PD-1 blockade without intestinal inflammation is achieved by elimination of FcγR interactions.
J Immunother Cancer
; 8(2)2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33127658
10.
Dinaciclib induces immunogenic cell death and enhances anti-PD1-mediated tumor suppression.
J Clin Invest
; 128(2): 644-654, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29337311
11.
GITR Agonism Enhances Cellular Metabolism to Support CD8+ T-cell Proliferation and Effector Cytokine Production in a Mouse Tumor Model.
Cancer Immunol Res
; 6(10): 1199-1211, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30154083
12.
Characterization of MK-4166, a Clinical Agonistic Antibody That Targets Human GITR and Inhibits the Generation and Suppressive Effects of T Regulatory Cells.
Cancer Res
; 77(16): 4378-4388, 2017 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28611044
13.
IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells.
Nat Med
; 18(7): 1069-76, 2012 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22772566
14.
C17 prevents inflammatory arthritis and associated joint destruction in mice.
PLoS One
; 6(7): e22256, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21799806
15.
IL-10 elicits IFNγ-dependent tumor immune surveillance.
Cancer Cell
; 20(6): 781-96, 2011 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-22172723
16.
Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation.
J Exp Med
; 206(3): 525-34, 2009 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-19273624